Cargando…
Reexamining cholinesterase inhibitors for the prevention and treatment of delirium in high-risk populations
Autores principales: | Lieberman, Ori J., Douglas, Vanja C., LaHue, Sara C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064732/ https://www.ncbi.nlm.nih.gov/pubmed/37004115 http://dx.doi.org/10.1186/s13054-023-04413-w |
Ejemplares similares
-
The One-Two Punch of Delirium and Dementia During the COVID-19 Pandemic and Beyond
por: LaHue, Sara C., et al.
Publicado: (2020) -
Predisposing and Precipitating Factors Associated With Delirium: A Systematic Review
por: Ormseth, Cora H., et al.
Publicado: (2023) -
KIBRA, MTNR1B, and FKBP5 genotypes are associated with decreased odds of incident delirium in elderly post-surgical patients
por: Terrelonge, Mark, et al.
Publicado: (2022) -
COVID-19 severity and age increase the odds of delirium in hospitalized adults with confirmed SARS-CoV-2 infection: a cohort study
por: LaHue, Sara C., et al.
Publicado: (2022) -
Nighttime dexmedetomidine for postoperative delirium prevention: a promising step forward
por: Devlin, John W., et al.
Publicado: (2022)